Sonia Vallet

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

Mariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima et al. · Blood · 2009 · 398 citations · Full text

Medicine, Immunology, Oncology +10

Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice

Siddhartha Mukherjee, Noopur Raje, Jesse Schoonmaker et al. · Journal of Clinical Investigation · 2008 · 240 citations · Full text

Medicine, Biomedical Engineering, Bone Metabolism +16

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

Sonia Vallet, Siddhartha Mukherjee, Nileshwari Vaghela et al. · Proceedings of the National Academy of Sciences · 2010 · 235 citations · Full text

Medicine, Cell Biology, Oncology +17

SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK

Yutaka Okawa, Teru Hideshima, Paul M. Steed et al. · Blood · 2008 · 209 citations · Full text

Medicine, Oncology, Pharmacology +16

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

Iris Breitkreutz, Marc S. Raab, Sonia Vallet et al. · Leukemia · 2008 · 209 citations

Medicine, Oncology, Pharmacology +16